IDEAS home Printed from https://ideas.repec.org/f/pva780.html
   My authors  Follow this author

Sotiris Vandoros

Personal Details

First Name:Sotiris
Middle Name:
Last Name:Vandoros
Suffix:
RePEc Short-ID:pva780
http://www.kcl.ac.uk/sspp/departments/management/people/academic/Vandoros,-Dr-Sotiris.aspx

Affiliation

(50%) Business School
King's College London

London, United Kingdom
http://www.kcl.ac.uk/business
RePEc:edi:dmkcluk (more details at EDIRC)

(50%) Harvard T.H. Chan School of Public Health, Department of Social & Behavioral Sciences

https://www.hsph.harvard.edu/social-and-behavioral-sciences/
Boston MA

Research output

as
Jump to: Working papers Articles

Working papers

  1. van der Windt, Peter Cornelis & Vandoros, Sotiris, 2020. "Democracy and Health: Evidence from Within-Country Heterogeneity in the Congo," SocArXiv kpwxz, Center for Open Science.
  2. Georgios Kavetsos & Ichiro Kawachi & Ilias Kyriopoulos & Sotiris Vandoros, 2018. "The effect of the Brexit referendum result on subjective well-being," CEP Discussion Papers dp1586, Centre for Economic Performance, LSE.
  3. Jofre-Bonet, M. & Serra-Sastre, V. & Vandoros, S., 2016. "Better Health in Times of Hardship?," Working Papers 16/09, Department of Economics, City University London.
  4. Hessel, Philipp & Vandoros, Sotiris & Avendano, Mauricio, 2014. "The differential impact of the financial crisis on health in Ireland and Greece: a quasi-experimental approach," LSE Research Online Documents on Economics 59610, London School of Economics and Political Science, LSE Library.
  5. Kanavos, Panos G. & Vandoros, Sotiris, 2011. "Determinants of branded prescription medicine prices in OECD countries," LSE Research Online Documents on Economics 36351, London School of Economics and Political Science, LSE Library.
  6. Vandoros, Sotiris & Carman, Katherine Grace, 2011. "Demand and pricing of preventative healthcare," LSE Research Online Documents on Economics 37159, London School of Economics and Political Science, LSE Library.

Articles

  1. Dioikitopoulos, Evangelos V. & Minos, Dimitrios & Vandoros, Sotiris, 2020. "The (Agri-)Cultural origins of obesity," Social Science & Medicine, Elsevier, vol. 244(C).
  2. Vandoros, Sotiris & Avendano, Mauricio & Kawachi, Ichiro, 2019. "The association between economic uncertainty and suicide in the short-run," Social Science & Medicine, Elsevier, vol. 220(C), pages 403-410.
  3. Petrou, Panagiotis & Vandoros, Sotiris, 2018. "Healthcare reforms in Cyprus 2013–2017: Does the crisis mark the end of the healthcare sector as we know it?," Health Policy, Elsevier, vol. 122(2), pages 75-80.
  4. Jofre-Bonet, Mireia & Serra-Sastre, Victoria & Vandoros, Sotiris, 2018. "The impact of the Great Recession on health-related risk factors, behaviour and outcomes in England," Social Science & Medicine, Elsevier, vol. 197(C), pages 213-225.
  5. van der Windt, Peter & Vandoros, Sotiris, 2017. "Democracy and health: Evidence from within-country heterogeneity in the Congo," Social Science & Medicine, Elsevier, vol. 194(C), pages 10-16.
  6. Petrou, Panagiotis & Vandoros, Sotiris, 2015. "Cyprus in crisis: Recent changes in the pharmaceutical market and options for further reforms without sacrificing access to or quality of treatment," Health Policy, Elsevier, vol. 119(5), pages 563-568.
  7. Liu, Guy & Mirzaei, Ali & Vandoros, Sotiris, 2014. "The impact of bank competition and concentration on industrial growth," Economics Letters, Elsevier, vol. 124(1), pages 60-63.
  8. Sotiris Vandoros & Georgios Kavetsos & Paul Dolan, 2014. "Greasy Roads: The Impact of Bad Financial News on Road Traffic Accidents," Risk Analysis, John Wiley & Sons, vol. 34(3), pages 556-566, March.
  9. Sotiris Vandoros & Panos Kanavos, 2014. "Parallel Trade and Pharmaceutical Prices: A Game-theoretic Approach and Empirical Evidence from the European Union," The World Economy, Wiley Blackwell, vol. 37(6), pages 856-880, June.
  10. Sotiris Vandoros, 2014. "Therapeutic Substitution Post‐Patent Expiry: The Cases Of Ace Inhibitors And Proton Pump Inhibitors," Health Economics, John Wiley & Sons, Ltd., vol. 23(5), pages 621-630, May.
  11. Sotiris Vandoros & Panos Kanavos, 2013. "The generics paradox revisited: empirical evidence from regulated markets," Applied Economics, Taylor & Francis Journals, vol. 45(22), pages 3230-3239, August.
  12. Sotiris Vandoros, 2013. "My five pounds are not as good as yours, so I will spend them," Experimental Economics, Springer;Economic Science Association, vol. 16(4), pages 546-559, December.
  13. Vandoros, Sotiris & Stargardt, Tom, 2013. "Reforms in the Greek pharmaceutical market during the financial crisis," Health Policy, Elsevier, vol. 109(1), pages 1-6.
  14. Bertoldi, A.D. & Barros, A.J.D. & Camargo, A.L. & Hallal, P.C. & Vandoros, S. & Wagner, A. & Ross-Degnan, D., 2011. "Household expenditures for medicines and the role of free medicines in the brazilian public health system," American Journal of Public Health, American Public Health Association, vol. 101(5), pages 916-921.
  15. Fritz von der Schulenburg & Sotiris Vandoros & Panos Kanavos, 2011. "The effects of drug market regulation on pharmaceutical prices in Europe: overview and evidence from the market of ACE inhibitors," Health Economics Review, Springer, vol. 1(1), pages 1-8, December.
  16. Kanavos, Panos G. & Vandoros, Sotiris, 2011. "Determinants of branded prescription medicine prices in OECD countries," Health Economics, Policy and Law, Cambridge University Press, vol. 6(3), pages 337-367, July.
  17. Panos Kanavos & Sotiris Vandoros, 2010. "Competition in prescription drug markets: is parallel trade the answer?," Managerial and Decision Economics, John Wiley & Sons, Ltd., vol. 31(5), pages 325-338.

Citations

Many of the citations below have been collected in an experimental project, CitEc, where a more detailed citation analysis can be found. These are citations from works listed in RePEc that could be analyzed mechanically. So far, only a minority of all works could be analyzed. See under "Corrections" how you can help improve the citation analysis.

Blog mentions

As found by EconAcademics.org, the blog aggregator for Economics research:
  1. Vandoros, Sotiris & Avendano, Mauricio & Kawachi, Ichiro, 2019. "The association between economic uncertainty and suicide in the short-run," Social Science & Medicine, Elsevier, vol. 220(C), pages 403-410.

    Mentioned in:

    1. Simon McNamara’s journal round-up for 21st January 2019
      by sjmcnamara1 in The Academic Health Economists' Blog on 2019-01-21 12:00:11

Working papers

  1. Georgios Kavetsos & Ichiro Kawachi & Ilias Kyriopoulos & Sotiris Vandoros, 2018. "The effect of the Brexit referendum result on subjective well-being," CEP Discussion Papers dp1586, Centre for Economic Performance, LSE.

    Cited by:

    1. Gamage, Danula K. & Kavetsos, Georgios & Mallick, Sushanta & Sevilla, Almudena, 2020. "Pay Transparency Initiative and Gender Pay Gap: Evidence from Research-Intensive Universities in the UK," IZA Discussion Papers 13635, Institute of Labor Economics (IZA).
    2. Saville, Christopher W.N., 2020. "Mental health consequences of minority political positions: The case of brexit," Social Science & Medicine, Elsevier, vol. 258(C).
    3. Liew, Tim & Goodwin, Robin & Walasek, Lukasz, 2020. "Voting patterns, revoking article 50 and antidepressant trends in England following the Brexit referendum," Social Science & Medicine, Elsevier, vol. 255(C).

  2. Hessel, Philipp & Vandoros, Sotiris & Avendano, Mauricio, 2014. "The differential impact of the financial crisis on health in Ireland and Greece: a quasi-experimental approach," LSE Research Online Documents on Economics 59610, London School of Economics and Political Science, LSE Library.

    Cited by:

    1. M. Sáez & J. Vidiella-Martin & Guillem López i Casasnovas, 2018. "Collateral damages of the great crisis in Spain. A longitudinal health study," Economics Working Papers 1603, Department of Economics and Business, Universitat Pompeu Fabra.
    2. Thompson, Kristina & Ophem, Johan van & Wagemakers, Annemarie, 2019. "Studying the impact of the Eurozone’s Great Recession on health: Methodological choices and challenges," Economics & Human Biology, Elsevier, vol. 35(C), pages 162-184.
    3. Petrou, Panagiotis & Vandoros, Sotiris, 2015. "Cyprus in crisis: Recent changes in the pharmaceutical market and options for further reforms without sacrificing access to or quality of treatment," Health Policy, Elsevier, vol. 119(5), pages 563-568.
    4. Jofre-Bonet, Mireia & Serra-Sastre, Victoria & Vandoros, Sotiris, 2018. "The impact of the Great Recession on health-related risk factors, behaviour and outcomes in England," Social Science & Medicine, Elsevier, vol. 197(C), pages 213-225.
    5. Jofre-Bonet, M. & Serra-Sastre, V. & Vandoros, S., 2016. "Better Health in Times of Hardship?," Working Papers 16/09, Department of Economics, City University London.
    6. Giovanni Piumatti, 2020. "Longitudinal Trends in Self-Rated Health During Times of Economic Uncertainty in Italy," Social Indicators Research: An International and Interdisciplinary Journal for Quality-of-Life Measurement, Springer, vol. 148(2), pages 599-633, April.

  3. Kanavos, Panos G. & Vandoros, Sotiris, 2011. "Determinants of branded prescription medicine prices in OECD countries," LSE Research Online Documents on Economics 36351, London School of Economics and Political Science, LSE Library.

    Cited by:

    1. Francisco J. Pallares & Adam G. Walke & Thomas M., 2014. "Are Online Pharmacy Prices Really Lower in Mexico?," Asian Economic and Financial Review, Asian Economic and Social Society, vol. 4(4), pages 416-431, April.
    2. Anna-Maria Fontrier & Jennifer Gill & Panos Kanavos, 2019. "International impact of external reference pricing: should national policy-makers care?," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 20(8), pages 1147-1164, November.
    3. Puig-Junoy, Jaume & López-Valcárcel, Beatriz González, 2014. "Launch prices for new pharmaceuticals in the heavily regulated and subsidized Spanish market, 1995–2007," Health Policy, Elsevier, vol. 116(2), pages 170-181.
    4. Fontrier, Anna-Maria & Gill, Jennifer & Kanavos, Panos, 2019. "International impact of external reference pricing: should national policy makers care?," LSE Research Online Documents on Economics 100929, London School of Economics and Political Science, LSE Library.
    5. Paolo Pertile & Simona Gamba & Martin Forster, 2018. "Free-Riding in Pharmaceutical Price Regulation: Theory and Evidence," Discussion Papers 18/04, Department of Economics, University of York.
    6. Fritz von der Schulenburg & Sotiris Vandoros & Panos Kanavos, 2011. "The effects of drug market regulation on pharmaceutical prices in Europe: overview and evidence from the market of ACE inhibitors," Health Economics Review, Springer, vol. 1(1), pages 1-8, December.
    7. Petrou, Panagiotis & Vandoros, Sotiris, 2015. "Cyprus in crisis: Recent changes in the pharmaceutical market and options for further reforms without sacrificing access to or quality of treatment," Health Policy, Elsevier, vol. 119(5), pages 563-568.
    8. Takizawa, Osamu & Urushihara, Hisashi & Tanaka, Shiro & Kawakami, Koji, 2015. "Price difference as a predictor of the selection between brand name and generic statins in Japan," Health Policy, Elsevier, vol. 119(5), pages 612-619.
    9. Stephan Eger & Jörg Mahlich, 2014. "Pharmaceutical regulation in Europe and its impact on corporate R&D," Health Economics Review, Springer, vol. 4(1), pages 1-9, December.
    10. Dominik J. Wettstein & Stefan Boes, 2019. "Effectiveness of National Pricing Policies for Patent-Protected Pharmaceuticals in the OECD: A Systematic Literature Review," Applied Health Economics and Health Policy, Springer, vol. 17(2), pages 143-162, April.
    11. Jennifer Gill & Anna-Maria Fontrier & Dionysis Kyriopoulos & Panos Kanavos, 2019. "Variations in external reference pricing implementation: does it matter for public policy?," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 20(9), pages 1375-1397, December.
    12. WARBURTON, Christopher E.S., 2019. "Uneasy Coexistence: Profit Maximization And Affordable Healthcare In The Us," Applied Econometrics and International Development, Euro-American Association of Economic Development, vol. 19(1), pages 55-80.
    13. Vogler, Sabine & Habimana, Katharina & Arts, Danielle, 2014. "Does deregulation in community pharmacy impact accessibility of medicines, quality of pharmacy services and costs? Evidence from nine European countries," Health Policy, Elsevier, vol. 117(3), pages 311-327.
    14. Vandoros, Sotiris & Stargardt, Tom, 2013. "Reforms in the Greek pharmaceutical market during the financial crisis," Health Policy, Elsevier, vol. 109(1), pages 1-6.
    15. Simona Gamba & Paolo Pertile & Sabine Vogler, 2020. "The impact of managed entry agreements on pharmaceutical prices," Health Economics, John Wiley & Sons, Ltd., vol. 29(S1), pages 47-62, October.

Articles

  1. Vandoros, Sotiris & Avendano, Mauricio & Kawachi, Ichiro, 2019. "The association between economic uncertainty and suicide in the short-run," Social Science & Medicine, Elsevier, vol. 220(C), pages 403-410.

    Cited by:

    1. Janke, Katharina & Lee, Kevin & Propper, Carol & Shields, Kalvinder K & Shields, Michael, 2020. "Macroeconomic Conditions and Health in Britain: Aggregation, Dynamics and Local Area Heterogeneity," CEPR Discussion Papers 14507, C.E.P.R. Discussion Papers.
    2. Vandoros, Sotiris, 2020. "Excess mortality during the Covid-19 pandemic: Early evidence from England and Wales," Social Science & Medicine, Elsevier, vol. 258(C).
    3. Georgios Kavetsos & Ichiro Kawachi & Ilias Kyriopoulos & Sotiris Vandoros, 2018. "The effect of the Brexit referendum result on subjective well-being," CEP Discussion Papers dp1586, Centre for Economic Performance, LSE.
    4. Kyriopoulos, Ilias & Nikoloski, Zlatko & Mossialos, Elias, 2019. "Does economic recession impact newborn health? Evidence from Greece," Social Science & Medicine, Elsevier, vol. 237(C), pages 1-1.
    5. Denneson, Lauren M. & Tompkins, Kyla J. & McDonald, Katie L. & Hoffmire, Claire A. & Britton, Peter C. & Carlson, Kathleen F. & Smolenski, Derek J. & Dobscha, Steven K., 2020. "Gender differences in the development of suicidal behavior among United States military veterans: A national qualitative study," Social Science & Medicine, Elsevier, vol. 260(C).
    6. Karras, Elizabeth & Stokes, Cara M. & Warfield, Sara C. & Barth, Shannon K. & Bossarte, Robert M., 2019. "A randomized controlled trial of public messaging to promote safe firearm storage among U.S. military veterans," Social Science & Medicine, Elsevier, vol. 241(C).
    7. Richardson, Cara & Robb, Kathryn A. & O'Connor, Rory C., 2021. "A systematic review of suicidal behaviour in men: A narrative synthesis of risk factors," Social Science & Medicine, Elsevier, vol. 276(C).
    8. Abdou, Rawayda & Cassells, Damien & Berrill, Jenny & Hanly, Jim, 2020. "An empirical investigation of the relationship between business performance and suicide in the US," Social Science & Medicine, Elsevier, vol. 264(C).
    9. Fabrice Kämpfen & Iliana V Kohler & Alberto Ciancio & Wändi Bruine de Bruin & Jürgen Maurer & Hans-Peter Kohler, 2020. "Predictors of mental health during the Covid-19 pandemic in the US: Role of economic concerns, health worries and social distancing," PLOS ONE, Public Library of Science, vol. 15(11), pages 1-13, November.
    10. Fridh, Maria & Rosvall, Maria & Lindström, Martin, 2020. "Poor psychological health and 5-year suicide mortality: A population-based prospective cohort study," Social Science & Medicine, Elsevier, vol. 258(C).

  2. Petrou, Panagiotis & Vandoros, Sotiris, 2018. "Healthcare reforms in Cyprus 2013–2017: Does the crisis mark the end of the healthcare sector as we know it?," Health Policy, Elsevier, vol. 122(2), pages 75-80.

    Cited by:

    1. Giammanco, Maria Daniela & Gitto, Lara, 2019. "Health expenditure and FDI in Europe," Economic Analysis and Policy, Elsevier, vol. 62(C), pages 255-267.

  3. Jofre-Bonet, Mireia & Serra-Sastre, Victoria & Vandoros, Sotiris, 2018. "The impact of the Great Recession on health-related risk factors, behaviour and outcomes in England," Social Science & Medicine, Elsevier, vol. 197(C), pages 213-225.

    Cited by:

    1. Kyriopoulos, Ilias & Nikoloski, Zlatko & Mossialos, Elias, 2019. "The impact of the Greek economic adjustment programme on household health expenditure," Social Science & Medicine, Elsevier, vol. 222(C), pages 274-284.
    2. Hoang, Dan & Kristoffersen, Ingebjørg & Li, Ian W., 2019. "All in the mind? Estimating the effect of mental health on health behaviours," Social Science & Medicine, Elsevier, vol. 225(C), pages 69-84.
    3. Vandoros, Sotiris & Avendano, Mauricio & Kawachi, Ichiro, 2019. "The association between economic uncertainty and suicide in the short-run," Social Science & Medicine, Elsevier, vol. 220(C), pages 403-410.
    4. De Cao, Elisabetta & McCormick, Barry & Nicodemo, Catia, 2019. "Does unemployment worsen babies' health? A tale of siblings, maternal behaviour and selection," LSE Research Online Documents on Economics 102270, London School of Economics and Political Science, LSE Library.
    5. Liew, Tim & Goodwin, Robin & Walasek, Lukasz, 2020. "Voting patterns, revoking article 50 and antidepressant trends in England following the Brexit referendum," Social Science & Medicine, Elsevier, vol. 255(C).
    6. Briody, Jonathan & Doyle, Orla & Kelleher, Cecily, 2020. "The effect of local unemployment on health: A longitudinal study of Irish mothers 2001-2011," Economics & Human Biology, Elsevier, vol. 37(C).
    7. Joana Cima & Alvaro S Almeida, 2018. "Health Expenditure, GDP Growth and the Financial Crisis: A Panel Data Analysis for OECD European Countries," FEP Working Papers 602, Universidade do Porto, Faculdade de Economia do Porto.
    8. Rainer Reile & Aleksei Baburin & Tatjana Veideman & Mall Leinsalu, 2020. "Long-term trends in the body mass index and obesity risk in Estonia: an age–period–cohort approach," International Journal of Public Health, Springer;Swiss School of Public Health (SSPH+), vol. 65(6), pages 859-869, July.
    9. Wang, Qing & Tapia Granados, José A., 2019. "Economic growth and mental health in 21st century China," Social Science & Medicine, Elsevier, vol. 220(C), pages 387-395.
    10. Hall, James & Goranitis, Ilias & Kigozi, Jesse & Guariglia, Alessandra, 2021. "New evidence on the impact of the Great Recession on health-compromising behaviours," Economics & Human Biology, Elsevier, vol. 41(C).

  4. Petrou, Panagiotis & Vandoros, Sotiris, 2015. "Cyprus in crisis: Recent changes in the pharmaceutical market and options for further reforms without sacrificing access to or quality of treatment," Health Policy, Elsevier, vol. 119(5), pages 563-568.

    Cited by:

    1. Vogler, Sabine & Zimmermann, Nina & de Joncheere, Kees, 2016. "Policy interventions related to medicines: Survey of measures taken in European countries during 2010–2015," Health Policy, Elsevier, vol. 120(12), pages 1363-1377.
    2. Lars Carlsen & Rainer Bruggemann, 2017. "Fragile State Index: Trends and Developments. A Partial Order Data Analysis," Social Indicators Research: An International and Interdisciplinary Journal for Quality-of-Life Measurement, Springer, vol. 133(1), pages 1-14, August.
    3. Petrou, Panagiotis, 2021. "The 2019 introduction of the new National Healthcare System in Cyprus," Health Policy, Elsevier, vol. 125(3), pages 284-289.
    4. Petrou, Panagiotis & Vandoros, Sotiris, 2018. "Healthcare reforms in Cyprus 2013–2017: Does the crisis mark the end of the healthcare sector as we know it?," Health Policy, Elsevier, vol. 122(2), pages 75-80.

  5. Liu, Guy & Mirzaei, Ali & Vandoros, Sotiris, 2014. "The impact of bank competition and concentration on industrial growth," Economics Letters, Elsevier, vol. 124(1), pages 60-63.

    Cited by:

    1. Habib Hussain Khan & Rubi Binit Ahmad & Chan Sok Gee, 2016. "Market Structure, Financial Dependence and Industrial Growth: Evidence from the Banking Industry in Emerging Asian Economies," PLOS ONE, Public Library of Science, vol. 11(8), pages 1-24, August.
    2. Tongurai, Jittima & Vithessonthi, Chaiporn, 2018. "The impact of the banking sector on economic structure and growth," International Review of Financial Analysis, Elsevier, vol. 56(C), pages 193-207.
    3. Hasan Dinçer & Ozlem Olgu Akdeniz & Umit Hacioglu, 2018. "Competitive strategy selection in the European banking sector using a hybrid decision-making approach," Zbornik radova Ekonomskog fakulteta u Rijeci/Proceedings of Rijeka Faculty of Economics, University of Rijeka, Faculty of Economics and Business, vol. 36(1), pages 213-242.
    4. Mirzaei, Ali & Grosse, Robert, 2019. "The interaction of quantity and quality of finance: Did it make industries more resilient to the recent global financial crisis?," International Review of Economics & Finance, Elsevier, vol. 64(C), pages 493-512.
    5. Ms. Deniz O Igan & Ali Mirzaei, 2020. "Does Going Tough on Banks Make the Going Get Tough? Bank Liquidity Regulations, Capital Requirements, and Sectoral Activity," IMF Working Papers 2020/103, International Monetary Fund.
    6. Bogdan Capraru & Nicoleta-Livia Pintilie, 2017. "Assessing competition in the European Union banking sector," The Review of Finance and Banking, Academia de Studii Economice din Bucuresti, Romania / Facultatea de Finante, Asigurari, Banci si Burse de Valori / Catedra de Finante, vol. 9(1), pages 007-026, June.
    7. Pradeepta Sethi, 2018. "Paradox of external finance in the Indian manufacturing sector," Journal of Financial Economic Policy, Emerald Group Publishing, vol. 10(1), pages 95-111, April.
    8. Mirzaei, Ali & Al-Khouri, Ritab Salem Farhan, 2016. "The resilience of oil-rich economies to the global financial crisis: Evidence from Kuwaiti financial and real sectors," Economic Systems, Elsevier, vol. 40(1), pages 93-108.
    9. Keil, Jan, 2017. "The trouble with approximating industry concentration from Compustat," Journal of Corporate Finance, Elsevier, vol. 45(C), pages 467-479.

  6. Sotiris Vandoros & Georgios Kavetsos & Paul Dolan, 2014. "Greasy Roads: The Impact of Bad Financial News on Road Traffic Accidents," Risk Analysis, John Wiley & Sons, vol. 34(3), pages 556-566, March.

    Cited by:

    1. Vandoros, Sotiris & Avendano, Mauricio & Kawachi, Ichiro, 2019. "The association between economic uncertainty and suicide in the short-run," Social Science & Medicine, Elsevier, vol. 220(C), pages 403-410.
    2. Corrado Giulietti & Mirco Tonin & Michael Vlassopoulos, 2018. "When the Market Drives you Crazy: Stock Market Returns and Fatal Car Accidents," CESifo Working Paper Series 7182, CESifo.
    3. Nikolaos Antonakakis & Nikolaos Antonakakis & Alan Collins, 2014. "Does Fiscal Consolidation Really Get You Down? Evidence from Suicide Mortality," Department of Economics Working Papers wuwp182, Vienna University of Economics and Business, Department of Economics.
    4. Borowiecki, Karol Jan & Kavetsos, Georgios, 2015. "In fatal pursuit of immortal fame: Peer competition and early mortality of music composers," Discussion Papers of Business and Economics 6/2015, University of Southern Denmark, Department of Business and Economics.
    5. Jofre-Bonet, M. & Serra-Sastre, V. & Vandoros, S., 2016. "Better Health in Times of Hardship?," Working Papers 16/09, Department of Economics, City University London.
    6. Antonakakis, Nikolaos & Collins, Alan, 2015. "The impact of fiscal austerity on suicide mortality: Evidence across the ‘Eurozone periphery’," Social Science & Medicine, Elsevier, vol. 145(C), pages 63-78.

  7. Sotiris Vandoros & Panos Kanavos, 2014. "Parallel Trade and Pharmaceutical Prices: A Game-theoretic Approach and Empirical Evidence from the European Union," The World Economy, Wiley Blackwell, vol. 37(6), pages 856-880, June.

    Cited by:

    1. Adrian Towse & Michele Pistollato & Jorge Mestre-Ferrandiz & Zeba Khan & Satyin Kaura & Louis Garrison, 2015. "European Union Pharmaceutical Markets: A Case for Differential Pricing?," International Journal of the Economics of Business, Taylor & Francis Journals, vol. 22(2), pages 263-275, July.

  8. Sotiris Vandoros, 2014. "Therapeutic Substitution Post‐Patent Expiry: The Cases Of Ace Inhibitors And Proton Pump Inhibitors," Health Economics, John Wiley & Sons, Ltd., vol. 23(5), pages 621-630, May.

    Cited by:

    1. Casanova-Juanes, Julieta & Mestre-Ferrandiz, Jorge & Espín-Balbino, Jaime, 2018. "Competition in the off-patent medicine market in Spain: The national reference pricing system versus the regional system of tendering for outpatient prescription medicines in Andalusia," Health Policy, Elsevier, vol. 122(12), pages 1310-1315.
    2. Kanavos, Panos, 2014. "Measuring performance in off-patent drug markets: A methodological framework and empirical evidence from twelve EU Member States," Health Policy, Elsevier, vol. 118(2), pages 229-241.
    3. Petrou, Panagiotis & Vandoros, Sotiris, 2015. "Cyprus in crisis: Recent changes in the pharmaceutical market and options for further reforms without sacrificing access to or quality of treatment," Health Policy, Elsevier, vol. 119(5), pages 563-568.
    4. Katharina Elisabeth Fischer & Tom Stargardt, 2016. "The diffusion of generics after patent expiry in Germany," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 17(8), pages 1027-1040, November.
    5. Victoria Serra-Sastre & Simona Bianchi & Jorge Mestre-Ferrandiz & Phill O’Neill, 2021. "Does NICE influence the adoption and uptake of generics in the UK?," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 22(2), pages 229-242, March.
    6. Takizawa, Osamu & Urushihara, Hisashi & Tanaka, Shiro & Kawakami, Koji, 2015. "Price difference as a predictor of the selection between brand name and generic statins in Japan," Health Policy, Elsevier, vol. 119(5), pages 612-619.
    7. Sabrina Terrizzi & Chad Meyerhoefer, 2020. "Estimates Of The Price Elasticity Of Switching Between Branded And Generic Drugs," Contemporary Economic Policy, Western Economic Association International, vol. 38(1), pages 94-108, January.

  9. Sotiris Vandoros & Panos Kanavos, 2013. "The generics paradox revisited: empirical evidence from regulated markets," Applied Economics, Taylor & Francis Journals, vol. 45(22), pages 3230-3239, August.

    Cited by:

    1. Micael Castanheira De Moura & Carmine Ornaghi & Georges Siotis, 2019. "The Unexpected Consequences of Generic Entry," Working Papers ECARES 2019-21, ULB -- Universite Libre de Bruxelles.
    2. Porath, Daniel, 2016. "Size and dynamics of order-of-entry effects in pharmaceutical markets," UASM Discussion Paper Series 4/2016, University of Applied Sciences Mainz.
    3. Puig-Junoy, Jaume & López-Valcárcel, Beatriz González, 2014. "Launch prices for new pharmaceuticals in the heavily regulated and subsidized Spanish market, 1995–2007," Health Policy, Elsevier, vol. 116(2), pages 170-181.
    4. Arvate, Paulo Roberto & Barbosa, Klênio & Gambardella, Dante, 2013. "Generic-branded drug competition and the price for pharmaceuticals in procurement auctions," Textos para discussão 333, FGV EESP - Escola de Economia de São Paulo, Fundação Getulio Vargas (Brazil).
    5. Kanavos, Panos, 2014. "Measuring performance in off-patent drug markets: A methodological framework and empirical evidence from twelve EU Member States," Health Policy, Elsevier, vol. 118(2), pages 229-241.
    6. Katharina Elisabeth Fischer & Tom Stargardt, 2016. "The diffusion of generics after patent expiry in Germany," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 17(8), pages 1027-1040, November.
    7. Michael Mueller & Alexander Frenzel, 2015. "Competitive pricing within pharmaceutical classes: evidence on “follow-on” drugs in Germany 1993–2008," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 16(1), pages 73-82, January.
    8. Castanheira, Micael & de Frutos, Maria-Angeles & Ornaghi, Carmine & Siotis, Georges, 2017. "The Unexpected Consequences of Asymmetric Competition. An Application to Big Pharma," CEPR Discussion Papers 11813, C.E.P.R. Discussion Papers.
    9. Costa-Font, Joan & Rudisill, Caroline & Tan, Stefanie, 2014. "Brand loyalty, patients and limited generic medicines uptake," Health Policy, Elsevier, vol. 116(2), pages 224-233.
    10. Vandoros, Sotiris & Stargardt, Tom, 2013. "Reforms in the Greek pharmaceutical market during the financial crisis," Health Policy, Elsevier, vol. 109(1), pages 1-6.
    11. Sotiris Vandoros, 2014. "Therapeutic Substitution Post‐Patent Expiry: The Cases Of Ace Inhibitors And Proton Pump Inhibitors," Health Economics, John Wiley & Sons, Ltd., vol. 23(5), pages 621-630, May.

  10. Sotiris Vandoros, 2013. "My five pounds are not as good as yours, so I will spend them," Experimental Economics, Springer;Economic Science Association, vol. 16(4), pages 546-559, December.

    Cited by:

    1. Runnemark, Emma & Hedman, Jonas & Xiao, Xiao, 2014. "Do Consumers Pay More Using Debit Cards than Cash? An Experiment," Working Papers 2014:21, Lund University, Department of Economics.
    2. David Fielding & Stephen Knowles, 2013. "Can You Spare Some Change For Charity? Experimental Evidence On Verbal Cues And Loose Change Effects In A Dictator Game," Working Papers 1318, University of Otago, Department of Economics, revised Nov 2013.
    3. Junyi Shen & Hiromasa Takahashi, 2015. "The Tangibility Effect of Paper Money and Coins in an Investment Experiment," Discussion Paper Series DP2015-41, Research Institute for Economics & Business Administration, Kobe University.

  11. Vandoros, Sotiris & Stargardt, Tom, 2013. "Reforms in the Greek pharmaceutical market during the financial crisis," Health Policy, Elsevier, vol. 109(1), pages 1-6.

    Cited by:

    1. Vogler, Sabine & Zimmermann, Nina & de Joncheere, Kees, 2016. "Policy interventions related to medicines: Survey of measures taken in European countries during 2010–2015," Health Policy, Elsevier, vol. 120(12), pages 1363-1377.
    2. Balasopoulos, T. & Charonis, A. & Athanasakis, K. & Kyriopoulos, J. & Pavi, E., 2017. "Why do generic drugs fail to achieve an adequate market share in Greece? Empirical findings and policy suggestions," Health Policy, Elsevier, vol. 121(3), pages 265-272.
    3. Ifanti, Amalia A. & Argyriou, Andreas A. & Kalofonou, Foteini H. & Kalofonos, Haralabos P., 2013. "Financial crisis and austerity measures in Greece: Their impact on health promotion policies and public health care," Health Policy, Elsevier, vol. 113(1), pages 8-12.
    4. Greta Falavigna & Roberto Ippoliti & Marinella Bertolotti & Franca Riva & Antonio Maconi, 2017. "Supportare la ricerca e l’innovazione in sanità tramite i modelli organizzativi: il caso dell’Azienda Ospedaliera “SS. Antonio e Biagio e Cesare Arrigo” di Alessandria/Supporting research and innovati," IRCrES Working Paper 201709, Research Institute on Sustainable Economic Growth - Moncalieri (TO) ITALY - former Institute for Economic Research on Firms and Growth - Moncalieri (TO) ITALY.
    5. José A. Tapia Granados & Javier M. Rodriguez, "undated". "Health, Economic Crisis, and Austerity: A Comparison of Greece, Finland, and Iceland," Mathematica Policy Research Reports 1cdbac6dc6c548e3877b7b180, Mathematica Policy Research.
    6. Simou, Effie & Koutsogeorgou, Eleni, 2014. "Effects of the economic crisis on health and healthcare in Greece in the literature from 2009 to 2013: A systematic review," Health Policy, Elsevier, vol. 115(2), pages 111-119.
    7. George Fragkiadakis & Michael Doumpos & Constantin Zopounidis & Christophe Germain, 2016. "Operational and economic efficiency analysis of public hospitals in Greece," Post-Print hal-01414677, HAL.
    8. George Fragkiadakis & Michael Doumpos & Constantin Zopounidis & Christophe Germain, 2016. "Operational and economic efficiency analysis of public hospitals in Greece," Annals of Operations Research, Springer, vol. 247(2), pages 787-806, December.
    9. Mastorakis, Kostis & Siskos, Eleftherios, 2016. "Value focused pharmaceutical strategy determination with multicriteria decision analysis techniques," Omega, Elsevier, vol. 59(PA), pages 84-96.
    10. Petrou, Panagiotis & Vandoros, Sotiris, 2015. "Cyprus in crisis: Recent changes in the pharmaceutical market and options for further reforms without sacrificing access to or quality of treatment," Health Policy, Elsevier, vol. 119(5), pages 563-568.
    11. Casagranda, Ivo & Costantino, Giorgio & Falavigna, Greta & Furlan, Raffaello & Ippoliti, Roberto, 2016. "Artificial Neural Networks and risk stratification models in Emergency Departments: The policy maker's perspective," Health Policy, Elsevier, vol. 120(1), pages 111-119.
    12. Cavalieri, Marina & Guccio, Calogero & Rizzo, Ilde, 2017. "On the role of environmental corruption in healthcare infrastructures: An empirical assessment for Italy using DEA with truncated regression approach," Health Policy, Elsevier, vol. 121(5), pages 515-524.
    13. Jaume Puig-Junoy & Santiago Rodríguez-Feijoó & Beatriz Lopez-Valcarcel, 2014. "Paying for Formerly Free Medicines in Spain After 1 Year of Co-Payment: Changes in the Number of Dispensed Prescriptions," Applied Health Economics and Health Policy, Springer, vol. 12(3), pages 279-287, June.
    14. Goranitis, Ilias & Siskou, Olga & Liaropoulos, Lycourgos, 2014. "Health policy making under information constraints: An evaluation of the policy responses to the economic crisis in Greece," Health Policy, Elsevier, vol. 117(3), pages 279-284.
    15. Quaglio, GianLuca & Karapiperis, Theodoros & Van Woensel, Lieve & Arnold, Elleke & McDaid, David, 2013. "Austerity and health in Europe," Health Policy, Elsevier, vol. 113(1), pages 13-19.

  12. Bertoldi, A.D. & Barros, A.J.D. & Camargo, A.L. & Hallal, P.C. & Vandoros, S. & Wagner, A. & Ross-Degnan, D., 2011. "Household expenditures for medicines and the role of free medicines in the brazilian public health system," American Journal of Public Health, American Public Health Association, vol. 101(5), pages 916-921.

    Cited by:

    1. Eduardo J. Gómez, 2016. "Confronting Health Inequalities in the BRICS: Political Institutions, Foreign Policy Aspirations and State-civil Societal Relationships," Global Policy, London School of Economics and Political Science, vol. 7(4), pages 500-509, November.

  13. Fritz von der Schulenburg & Sotiris Vandoros & Panos Kanavos, 2011. "The effects of drug market regulation on pharmaceutical prices in Europe: overview and evidence from the market of ACE inhibitors," Health Economics Review, Springer, vol. 1(1), pages 1-8, December.

    Cited by:

    1. Tomasz Zaprutko & Dorota Kopciuch & Krzysztof Kus & Piotr Merks & Monika Nowicka & Izabela Augustyniak & Elżbieta Nowakowska, 2017. "Affordability of medicines in the European Union," PLOS ONE, Public Library of Science, vol. 12(2), pages 1-13, February.
    2. Carone, Giuseppe & Schwierz, Christoph & Xavier, Ana, 2012. "Cost-containment policies in public pharmaceutical spending in the EU," MPRA Paper 42008, University Library of Munich, Germany.
    3. Nika Marđetko & Mitja Kos, 2018. "Introduction of therapeutic reference pricing in Slovenia and its economic consequences," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 19(4), pages 571-584, May.
    4. Fabio Pammolli & Armando Rungi, 2016. "Access to Medicines and European Market Integration," Working Papers 01/2016, IMT School for Advanced Studies Lucca, revised Jan 2016.
    5. Stephan Eger & Jörg Mahlich, 2014. "Pharmaceutical regulation in Europe and its impact on corporate R&D," Health Economics Review, Springer, vol. 4(1), pages 1-9, December.
    6. Dominik J. Wettstein & Stefan Boes, 2019. "Effectiveness of National Pricing Policies for Patent-Protected Pharmaceuticals in the OECD: A Systematic Literature Review," Applied Health Economics and Health Policy, Springer, vol. 17(2), pages 143-162, April.
    7. Sotiris Vandoros, 2014. "Therapeutic Substitution Post‐Patent Expiry: The Cases Of Ace Inhibitors And Proton Pump Inhibitors," Health Economics, John Wiley & Sons, Ltd., vol. 23(5), pages 621-630, May.
    8. Leopold, Christine & Mantel-Teeuwisse, Aukje Katja & Vogler, Sabine & de Joncheere, Kees & Laing, Richard Ogilvie & Leufkens, Hubert G.M., 2013. "Is Europe still heading to a common price level for on-patent medicines? An exploratory study among 15 Western European countries," Health Policy, Elsevier, vol. 112(3), pages 209-216.
    9. Andia, Tatiana & Mantilla, Cesar & Morales, Alvaro & Ortiz, Santiago & Rodriguez-Lesmes, Paul, 2020. "Does price-cap regulation work for increasing access to contraceptives? Aggregate- and pharmacy-level evidence from Colombia," SocArXiv cq7d2, Center for Open Science.
    10. Park, Sun-Young & Han, Euna & Kim, Jini & Lee, Eui-Kyung, 2016. "Factors influencing the difference between forecasted and actual drug sales volumes under the price–volume agreement in South Korea," Health Policy, Elsevier, vol. 120(8), pages 867-874.
    11. Adrian Towse & Michele Pistollato & Jorge Mestre-Ferrandiz & Zeba Khan & Satyin Kaura & Louis Garrison, 2015. "European Union Pharmaceutical Markets: A Case for Differential Pricing?," International Journal of the Economics of Business, Taylor & Francis Journals, vol. 22(2), pages 263-275, July.

  14. Kanavos, Panos G. & Vandoros, Sotiris, 2011. "Determinants of branded prescription medicine prices in OECD countries," Health Economics, Policy and Law, Cambridge University Press, vol. 6(3), pages 337-367, July.
    See citations under working paper version above.
  15. Panos Kanavos & Sotiris Vandoros, 2010. "Competition in prescription drug markets: is parallel trade the answer?," Managerial and Decision Economics, John Wiley & Sons, Ltd., vol. 31(5), pages 325-338.

    Cited by:

    1. Dubois, Pierre & Saethre, Morten, 2018. "On the Effect of Parallel Trade on Manufacturers' and Retailers' Profits in the Pharmaceutical Sector," CEPR Discussion Papers 12649, C.E.P.R. Discussion Papers.
    2. David Granlund & Miyase Koksal-Ayhan, 2015. "Parallel imports and a mandatory substitution reform: a kick or a muff for price competition in pharmaceuticals?," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 16(9), pages 969-983, December.
    3. Hostenkamp, Gisela & Kronborg, Christian & Arendt, Jacob Nielsen, 2012. "Parallel imports of hospital pharmaceuticals: An empirical analysis of price effects from parallel imports and the design of procurement procedures in the Danish hospital sector," Discussion Papers of Business and Economics 16/2012, University of Southern Denmark, Department of Business and Economics.
    4. Granlund David & Köksal-Ayhan Miyase Yesim, 2016. "EU Enlargement, Parallel Trade and Price Competition in Pharmaceuticals: Has the Price Competition increased?," The B.E. Journal of Economic Analysis & Policy, De Gruyter, vol. 16(2), pages 1069-1092, April.
    5. Duso, T. & Herr, A. & Suppliet, M, 2014. "The Welfare Impact of Parallel Imports: A Structural Approach Applied to the German Market for Oral Anti-diabetics," Health, Econometrics and Data Group (HEDG) Working Papers 14/09, HEDG, c/o Department of Economics, University of York.

More information

Research fields, statistics, top rankings, if available.

Statistics

Access and download statistics for all items

Co-authorship network on CollEc

NEP Fields

NEP is an announcement service for new working papers, with a weekly report in each of many fields. This author has had 4 papers announced in NEP. These are the fields, ordered by number of announcements, along with their dates. If the author is listed in the directory of specialists for this field, a link is also provided.
  1. NEP-EUR: Microeconomic European Issues (2) 2018-12-17 2019-02-04
  2. NEP-HAP: Economics of Happiness (2) 2018-12-17 2019-02-04
  3. NEP-HEA: Health Economics (2) 2015-10-25 2020-02-10
  4. NEP-INT: International Trade (2) 2018-12-17 2019-02-04

Corrections

All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. For general information on how to correct material on RePEc, see these instructions.

To update listings or check citations waiting for approval, Sotiris Vandoros should log into the RePEc Author Service.

To make corrections to the bibliographic information of a particular item, find the technical contact on the abstract page of that item. There, details are also given on how to add or correct references and citations.

To link different versions of the same work, where versions have a different title, use this form. Note that if the versions have a very similar title and are in the author's profile, the links will usually be created automatically.

Please note that most corrections can take a couple of weeks to filter through the various RePEc services.

IDEAS is a RePEc service hosted by the Research Division of the Federal Reserve Bank of St. Louis . RePEc uses bibliographic data supplied by the respective publishers.